Europe — EMA
Nanotop (Human Serum Albumin)
GNH USA supplies Nanotop (Human Serum Albumin), a human serum albumin for volume expansion and hypoalbuminemia treatment. Request a quote for global supply.
Request sourcing
What is Human Serum Albumin?
Human Serum Albumin, the active ingredient in Nanotop, is a human serum albumin presented as a sterile solution for subcutaneous use. It helps restore plasma oncotic pressure and expand intravascular volume in patients with hypoalbuminemia, severe burns, trauma, or postoperative fluid loss and support hemodynamic stability.
GNH USA supplies Nanotop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. Our distribution network ensures timely delivery and regulatory compliance across EU and global markets.
What is Human Serum Albumin used for?
Nanotop (human serum albumin) is used as a plasma volume expander in conditions associated with low oncotic pressure.
Hypovolemia: restores circulating volume and improves blood pressure. Hypoalbuminemia: raises serum albumin concentrations and reduces edema. Burns: compensates fluid loss and maintains oncotic pressure. Surgical patients: supports hemodynamic stability during major operations.
What are the side effects of Human Serum Albumin?
Human serum albumin may be associated with infusion‑related reactions and, rarely, severe systemic events.
Common Side Effects: - Fever or chills. - Injection site pain. - Headache. - Nausea. - Hypotension. - Rash.
Serious or Rare Side Effects: - Anaphylactic reaction. - Volume overload leading to pulmonary edema. - Hemolysis. - Transmission of infectious agents. - Severe hypertension. - Thromboembolic events.
What precautions apply to Human Serum Albumin?
When using Nanotop, consider the following precautions.
Assess albumin level: measure serum albumin before initiating therapy. Monitor fluid balance: track input/output and weight to avoid overload. Check for hypersensitivity: observe for signs of allergic reaction during infusion. Avoid in patients with congestive heart failure: risk of volume overload. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Serum Albumin interact with?
Human serum albumin can influence the pharmacokinetics of several co‑administered drugs.
Major Interactions (Avoid): - Highly protein‑bound drugs such as warfarin or phenytoin may have altered free concentrations. - ACE inhibitors may potentiate hypotension. - Diuretics may increase risk of volume depletion.
Moderate Interactions (Monitor Closely): - Thyroid hormones may have altered distribution. - Certain antibiotics (e.g., ceftriaxone) bind albumin and could affect levels. - Immunosuppressants such as cyclosporine may have changed pharmacokinetics.



